Foster Wayne Insider Trades

Insider Trading History

Track insider trading activity for Foster Wayne. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $334k 79,329 shares
Last Trade
Jan 31, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$51.4k 12,132 shares
$4.24
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $0 0 shares
Last Trade
Jan 31, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.9k 8,000 shares
$4.24
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $455k 108,000 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$458k 108,000 shares
$4.24
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $385k 91,461 shares
Last Trade
Jan 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$175k 41,333 shares
$4.24
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $211k 50,128 shares
Last Trade
Jan 31, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$36.9k 12,062 shares
$3.06
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $506k 120,100 shares
Last Trade
Jan 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$416k 136,100 shares
$3.06
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $140k 33,333 shares
Last Trade
Jan 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 33,333 shares
$3.06
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $228k 54,190 shares
Last Trade
Jan 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 33,333 shares
$3.06
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $87.8k 20,857 shares
Last Trade
Feb 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$47.9k 12,477 shares
$3.84
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $140k 33,334 shares
Last Trade
Jan 31, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$139k 33,334 shares
$4.16
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $506k 120,100 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 120,100 shares
$4.16
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $281k 66,666 shares
Last Trade
Jan 31, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$139k 33,334 shares
$4.16
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $589k 140,000 shares
Last Trade
Jan 31, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$648k 140,000 shares
$4.63
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
Evp, Chief Accounting Officer
Holding Value $505k 120,000 shares
Last Trade
Jan 31, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$857k 120,000 shares
$7.14
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
See Remarks
Holding Value $302k 71,750 shares
Last Trade
Jan 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.24M 71,750 shares
$73.00
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
See Remarks
Holding Value $168k 40,000 shares
Last Trade
Oct 29, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$4.21
Atea Pharmaceuticals
Atea Pharmaceuticals AVIR
See Remarks
Holding Value $0 0 shares
Last Trade
Oct 29, 2020 Sale
No data
No data
$4.21
Mersana Therapeutics
Mersana Therapeutics MRSN
Vice President Of Finance
Holding Value $894k 30,750 shares
Last Trade
Jan 23, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.7M 30,750 shares
$87.75
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vice President Of Finance
Holding Value $589k 20,250 shares
Last Trade
Feb 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.2M 20,250 shares
$355.75
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Vice President Of Finance
Holding Value $2.07M 71,083 shares
Last Trade
Jan 30, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$5.52M 14,705 shares
$375.50
$29.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up